Videos

Dr. Steven Edelman talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the making of a good presentation.

Dr. Steven Edelman talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the A1C he would strive for, if he didn't have diabetes, and what he'd strive for when working with his patients.

Dr. Steven Edelman talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the importance of food control along with exercise.

In this Exclusive Interview, Dr. Hartman discuss practical points in the approach of the patient with diabetes, hyperlipidemia and obesity.

Dr. Ralph Defronzo, MD, speaks about the current variability of diabetes medication as well as their effectiveness but lack of affordability, and he places a special emphasis on the effectiveness of triple therapy in the treatment of diabetes. Dr. Defronzo is a Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Diabetes Center in San Antonia, Texas. Dr. Defronzo is also Deputy Director of the Texas Diabetes Institute.

Dr. Ralph Defronzo discusses the current treatment landscape for diabetes, the effectiveness of various drugs and his preference for the "triple therapy."

Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Sessions in San Diego. Dr. Defronzo shares his thoughts on A1C, his preferred medications to treat diabetes, getting ahead of prediabetes, and beta cell regeneration.

Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the major changes he has seen in diabetes treatment in the past 50 years.

Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about the usefulness and the problem with the A1C test.

Dr. Ralph Defronzo talks with Diabetes in Control Publisher Steve Freed during the ADA 77th Scientific Session in San Diego about SGLT-2, GLP-1, and the drugs he recommends despite standard practice.